Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

ivf

  • Home
  •  
  • ivf



  • Most Read
  • Latest Comments
  • India records 10 new live births using Memphasys’ sperm selection device Felix
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • India records 10 new live births using Memphasys’ sperm selection device Felix
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • India records 10 new live births using Memphasys’ sperm selection device Felix
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • India records 10 new live births using Memphasys’ sperm selection device Felix
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • India records 10 new live births using Memphasys’ sperm selection device Felix
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • India records 10 new live births using Memphasys’ sperm selection device Felix
    India records 10 new live births using Memphasys’ sperm selection device Felix
    • News

  • Rising demand for IVF from LGBTQI+ community driving Monash IVF market share
    Rising demand for IVF from LGBTQI+ community driving Monash IVF market share
    • News

  • Amid declining population, Memphasys and Vitrolife team up to provide IVF treatments to boost numbers
    Amid declining population, Memphasys and Vitrolife team up to provide IVF treatments to boost numbers
    • News

  • Memphasys’s IVF treatment births baby boy in India, available in Japan now
    Memphasys’s IVF treatment births baby boy in India, available in Japan now
    • News

  • Monash IVF joins M&A arms race with entry into Perth IVF market via acquisition
    Monash IVF joins M&A arms race with entry into Perth IVF market via acquisition
    • News

  • India records 10 new live births using Memphasys’ sperm selection device Felix
    • News

    India records 10 new live births using Memphasys’ sperm selection device Felix

    One in 15 Indian couples struggle with infertility, with the figure standing at one in six in Australia. IVF then becomes a viable option, with one in 20 Aussie couples opting for the procedure. Even so, with sperm deterioration over time, the IVF process becomes trickier. That’s where Felix comes in. Developed by Australian reproductive

    Read More
    Public
  • Rising demand for IVF from LGBTQI+ community driving Monash IVF market share
    • News

    Rising demand for IVF from LGBTQI+ community driving Monash IVF market share

    Despite the rising cost of living and depression in discretionary spending, fertility company Monash IVF (ASX: MVF) has seen no downturn in demand, despite a round of IVF treatment often costing upwards of $10,000 with no guaranteed success. The broader de-stigmatisation of IVF in Australia through open discussion, media publicity and progressive LGBTIQ+ community have

    Read More
    Public
  • Amid declining population, Memphasys and Vitrolife team up to provide IVF treatments to boost numbers
    • News

    Amid declining population, Memphasys and Vitrolife team up to provide IVF treatments to boost numbers

    For over seven years, Japan’s birth rate has been witnessing a decline. Its fertility rate has fallen below the rate required to maintain a population. Of course, the consequences are dire, ranging from a small labour force to vulnerable borders. The Japanese government has been investing in developing childcare packages to entice people into having

    Read More
    Public
  • Memphasys’s IVF treatment births baby boy in India, available in Japan now
    • News

    Memphasys’s IVF treatment births baby boy in India, available in Japan now

    Last year, in a bid to address the country’s low fertility rate, the Japanese government announced that it will cover 70% of the costs of IVF treatments. As people rushed to IVF clinics, companies like biotech company Memphasys (ASX: MEM) saw their time to shine.  Memphasys offers the Felix System, a patented, automated single-use cartridge

    Read More
    Public
  • Monash IVF joins M&A arms race with entry into Perth IVF market via acquisition
    • News

    Monash IVF joins M&A arms race with entry into Perth IVF market via acquisition

    IVF – they are the three hottest letters across corporate Australia at the moment with major interest from private equity firms around the world keen for a slice of the IVF market where many of the industry’s pioneers and leading scientists were born.  Through a combination of wider acceptability and openness of IVF discussions amongst

    Read More
    Public
  • Virtus Health gains market share in IVF space as demand continues to grow
    • News

    Virtus Health gains market share in IVF space as demand continues to grow

    It’s not up for debate- a woman’s body is her own. And yet, lots of people have lots to say about women’s bodies and what they should and shouldn’t be able to do.  With the abortion debate at boiling point in America following a major backwards step in legislation, the rights of women are yet

    Read More
    Public
  • 1
  • 2

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.